Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy

被引：0
作者：
Wang, Jing [1 ]
Wang, Xiaomin [1 ]
Ma, Tianpeng [2 ]
Xie, Yiqiang [2 ]
机构：
[1] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
[2] Hainan Med Univ, Haikou, Hainan, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
diabetic nephropathy; Alpinia oxyphylla; Chinese herbal medicine; mechanism; research progress; CHRONIC KIDNEY-DISEASE; STAGE; 4; BARDOXOLONE METHYL; OXIDATIVE STRESS; PODOCYTE INJURY; GUT MICROBIOME; INFLAMMATION; AUTOPHAGY; RISK; HYPERGLYCEMIA;
D O I：
10.3389/fphar.2024.1390672
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Diabetic nephropathy (DN) constitutes a major microvascular complication of diabetes and is a primary cause of mortality in diabetic individuals. With the global rise in diabetes, DN has become an urgent health issue. Currently, there is no definitive cure for DN. Alpinia oxyphylla, a Chinese herbal medicine traditionally used, exhibits a wide range of pharmacological effects and is frequently used in the prevention and management of DN. This paper offers an extensive review of the biological mechanisms by which A. oxyphylla delivers therapeutic advantages in DN management. These mechanisms include activating podocyte autophagy, regulating non-coding RNA, modulating gut microbiota, alleviating lipotoxicity, counteracting oxidative stress, and diminishing inflammatory responses, underscoring the therapeutic potential of A. oxyphylla in DN treatment.
引用
收藏
页数：11
相关论文
共 126 条
  • [1] Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways
    Al-Bari, Md Abdul Alim
    Xu, Pingyong
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1467 (01) : 3 - 20
  • [2] Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice
    Albuquerque, R. C. M. F.
    Brandao, A. B. P.
    De Abreu, I. C. M. E.
    Ferreira, F. G.
    Santos, L. B.
    Moreira, L. N.
    Taddei, C. R.
    Aimbire, F.
    Cunha, T. S.
    [J]. BENEFICIAL MICROBES, 2019, 10 (08) : 901 - 912
  • [3] Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy (vol 8, e77468, 2013)
    Alvarez, M. Lucrecia
    Khosroheidari, Mahdieh
    Eddy, Elena
    Kiefer, Jeff
    DiStefano, Johanna K.
    [J]. PLOS ONE, 2016, 11 (12):
  • [4] Mechanisms of podocyte injury and implications for diabetic nephropathy
    Barutta, Federica
    Bellini, Stefania
    Gruden, Gabriella
    [J]. CLINICAL SCIENCE, 2022, 136 (07) : 493 - 520
  • [5] Interleukin-1β Gene (IL1B) Polymorphism and Risk of Developing Diabetic Nephropathy
    Buraczynska, Monika
    Ksiazek, Katarzyna
    Wacinski, Piotr
    Zaluska, Wojciech
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (06) : 577 - 584
  • [6] Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice
    Butler, M
    McKay, RA
    Popoff, IJ
    Gaarde, WA
    Witchell, D
    Murray, SF
    Dean, NM
    Bhanot, S
    Monia, BP
    [J]. DIABETES, 2002, 51 (04) : 1028 - 1034
  • [7] Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
    Cani, Patrice D.
    de Vos, Willem M.
    [J]. FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [8] Chen F., 2016, Chin. Archives Traditional Chin. Med, V34, P2346, DOI [10.13193/j.issn.1673-7717.2016.10.011, DOI 10.13193/J.ISSN.1673-7717.2016.10.011]
  • [9] RETRACTED: Down-regulation of microRNA-21 reduces inflammation and podocyte apoptosis in diabetic nephropathy by relieving the repression of TIMP3 expression (Retracted Article)
    Chen, Xiaoping
    Zhao, Lei
    Xing, Yanwei
    Lin, Bo
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 : 7 - 14
  • [10] Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
    Chin, Melanie P.
    Bakris, George L.
    Block, Geoffrey A.
    Chertow, Glenn M.
    Goldsberry, Angie
    Inker, Lesley A.
    Heerspink, Hiddo J. L.
    O'Grady, Megan
    Pergola, Pablo E.
    Wanner, Christoph
    Warnock, David G.
    Meyer, Colin J.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (01) : 40 - 47
12345678910